Home › Idiopathic Pulmonary Fibrosis › Kansas › Kansas City
Idiopathic Pulmonary Fibrosis clinical trials in Kansas City, KS
7 studies for Idiopathic Pulmonary Fibrosis are looking for participants at sites in and around Kansas City (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
An Extension Study of Subjects Who Received an Avalyn Inhaled Antifibrotic Agent (SAIL)
RecruitingPhase 2
- The University of Kansas Medical Center, Kansas City
A Phase IIb Study to Evaluate AZD8965 in Participants With IPF.
RecruitingPhase 2
- Research Site, Kansas City
RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
RecruitingPhase 2
- The University of Kansas Medical Center, Kansas City
A Phase 2 Study of LTI-03 in Patients With Idiopathic Pulmonary Fibrosis
RecruitingPhase 2
- University of Kansas Medical Center, Kansas City
Oral Ifetroban in Patients With Idiopathic Pulmonary Fibrosis (IPF)
RecruitingPhase 2
- University of Kansas, Kansas City
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
RecruitingPhase 2
- WISPer site in Kansas City, KS, Kansas City
Interstitial Lung Disease Research Unit Biobank
RecruitingObservational study
- The University of Kansas Medical Center, Kansas City
Idiopathic Pulmonary Fibrosis trials in other cities
- Birmingham, AL9 studies
- New York City, NY8 studies
- Los Angeles, CA7 studies
- Philadelphia, PA7 studies
- Chicago, IL6 studies
- Aurora, CO6 studies
- Durham, NC6 studies
- Nashville, TN5 studies
- Dallas, TX5 studies
- Houston, TX5 studies
- Charleston, SC5 studies
- Atlanta, GA5 studies
Other studies in Kansas City
- Cardiovascular Disease14 studies
- Heart Failure13 studies
- Obesity13 studies
- Interstitial Lung Diseases13 studies
- Cystic Fibrosis13 studies
- Breast Cancer12 studies
- Bladder Cancer12 studies
- Acute Myeloid Leukemia12 studies
- Prostate Cancer12 studies
- Non-Small Cell Lung Cancer11 studies
- Lung Cancer11 studies
- COPD9 studies
From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.